Cargando…

Development of QSAR models for in silico screening of antibody solubility

Although monoclonal antibodies (mAbs) have been shown to be extremely effective in treating a number of diseases, they often suffer from poor developability attributes, such as high viscosity and low solubility at elevated concentrations. Since experimental candidate screening is often materials and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Xuan, Shih, James, Lin, Yuhao, Chai, Qing, Cramer, Steven M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037471/ https://www.ncbi.nlm.nih.gov/pubmed/35442164 http://dx.doi.org/10.1080/19420862.2022.2062807

Ejemplares similares

In Silico Rational Design and Virtual Screening of Bioactive Peptides Based on QSAR Modeling
por: Mahmoodi-Reihani, Mehri, et al.
Publicado: (2020)

Rapid and accurate in silico solubility screening of a monoclonal antibody library
por: Sormanni, Pietro, et al.
Publicado: (2017)

Chemometric QSAR Modeling and In Silico Design of Antioxidant NO Donor Phenols
por: Mitra, Indrani, et al.
Publicado: (2011)

The inevitable QSAR renaissance
por: Cramer, Richard D.
Publicado: (2011)

Antibody apparent solubility prediction from sequence by transfer learning
por: Feng, Jiangyan, et al.
Publicado: (2022)

Multi-target QSAR modelling in the analysis and design of HIV-HCV co-inhibitors: an in-silico study
por: Liu, Qi, et al.
Publicado: (2011)

Rethinking 3D-QSAR
por: Cramer, Richard D.
Publicado: (2010)

Quinazoline analogues as cytotoxic agents; QSAR, docking, and in silico studies
por: Emami, Leila, et al.
Publicado: (2021)

3D QSAR Pharmacophore Modeling, in Silico Screening, and Density Functional Theory (DFT) Approaches for Identification of Human Chymase Inhibitors
por: Arooj, Mahreen, et al.
Publicado: (2011)

In Silico Prediction of PAMPA Effective Permeability Using a Two-QSAR Approach
por: Chi, Cheng-Ting, et al.
Publicado: (2019)

Evaluation of QSAR Equations for Virtual Screening
por: Spiegel, Jacob, et al.
Publicado: (2020)

In Silico Prediction of Skin Permeability Using a Two-QSAR Approach
por: Wu, Yu-Wen, et al.
Publicado: (2022)

QSAR workbench: automating QSAR modeling to drive compound design
por: Cox, Richard, et al.
Publicado: (2013)

Construction of a QSAR Model Based on Flavonoids and Screening of Natural Pancreatic Lipase Inhibitors
por: Yuan, Yutong, et al.
Publicado: (2023)

Synthetic Analogues of Aminoadamantane as Influenza Viral Inhibitors—In Vitro, In Silico and QSAR Studies
por: Chayrov, Radoslav, et al.
Publicado: (2020)

In Silico Prediction of the Toxicity of Nitroaromatic Compounds: Application of Ensemble Learning QSAR Approach
por: Daghighi, Amirreza, et al.
Publicado: (2022)

Methodology of aiQSAR: a group-specific approach to QSAR modelling
por: Vukovic, Kristijan, et al.
Publicado: (2019)

QSAR-Co-X: an open source toolkit for multitarget QSAR modelling
por: Halder, Amit Kumar, et al.
Publicado: (2021)

In-silico combinatorial design and pharmacophore modeling of potent antimalarial 4-anilinoquinolines utilizing QSAR and computed descriptors
por: Parihar, Neha, et al.
Publicado: (2015)

QSAR Modeling of Imbalanced High-Throughput Screening Data in PubChem
por: Zakharov, Alexey V., et al.
Publicado: (2014)

Development of QSAR model for immunomodulatory activity of natural coumarinolignoids
por: Yadav, Dharmendra K, et al.
Publicado: (2010)

In silico prediction of aqueous solubility – classification models
por: Kramer, C, et al.
Publicado: (2008)

In silico screening for identification of novel β-1,3-glucan synthase inhibitors using pharmacophore and 3D-QSAR methodologies
por: Meetei, Potshangbam Angamba, et al.
Publicado: (2016)

Using Topological Indices to Predict Anti-Alzheimer and Anti-Parasitic GSK-3 Inhibitors by Multi-Target QSAR in Silico Screening
por: García, Isela, et al.
Publicado: (2010)

In-silico modelling studies of 5-benzyl-4-thiazolinone derivatives as influenza neuraminidase inhibitors via 2D-QSAR, 3D-QSAR, molecular docking, and ADMET predictions
por: Abdullahi, Mustapha, et al.
Publicado: (2022)

QSAR DataBank - an approach for the digital organization and archiving of QSAR model information
por: Ruusmann, Villu, et al.
Publicado: (2014)

Separating clinical antibodies from repertoire antibodies, a path to in silico developability assessment
por: Negron, Christopher, et al.
Publicado: (2022)

Benchmarks for interpretation of QSAR models
por: Matveieva, Mariia, et al.
Publicado: (2021)

Novel Lipids to Regulate Obesity and Brain Function: Comparing Available Evidence and Insights from QSAR In Silico Models
por: Teixeira, Francisca S., et al.
Publicado: (2023)

Development of QSAR models to predict blood-brain barrier permeability
por: Faramarzi, Sadegh, et al.
Publicado: (2022)

2D-QSAR and 3D-QSAR Analyses for EGFR Inhibitors
por: Zhao, Manman, et al.
Publicado: (2017)

Structure-free antibody paratope similarity prediction for in silico epitope binning via protein language models
por: Ghanbarpour, Ahmadreza, et al.
Publicado: (2023)

In silico screening and heterologous expression of soluble dimethyl sulfide monooxygenases of microbial origin in Escherichia coli
por: Karaiyan, Prasanth, et al.
Publicado: (2022)

A combined 3D-QSAR and docking studies for the In-silico prediction of HIV-protease inhibitors
por: Ul-Haq, Zaheer, et al.
Publicado: (2013)

Novel ligands of Choline Acetyltransferase designed by in silico molecular docking, hologram QSAR and lead optimization
por: Kumar, Rajnish, et al.
Publicado: (2016)

3D-QSAR and in-silico Studies of Natural Products and Related Derivatives as Monoamine Oxidase Inhibitors
por: Dhiman, Priyanka, et al.
Publicado: (2018)

In Silico Exploration of Aryl Halides Analogues as Checkpoint Kinase 1 Inhibitors by Using 3D QSAR, Molecular Docking Study, and ADMET Screening
por: Ghaleb, Adib, et al.
Publicado: (2019)

DPubChem: a web tool for QSAR modeling and high-throughput virtual screening
por: Soufan, Othman, et al.
Publicado: (2018)

Validation of QSAR models for legislative purposes
por: Tichý, Miloň, et al.
Publicado: (2009)

New public QSAR model for carcinogenicity
por: Fjodorova, Natalja, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_jeiv3l7j75pjk7946jlt7o0ls5